Pain QX
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Grant | ||
$10.0k | Grant | ||
N/A | $330k | Seed | |
N/A | Angel | ||
N/A | Early VC | ||
$1.4m | Grant | ||
N/A | N/A | Early VC | |
$740k | Seed | ||
Total Funding | AUD3.8m |
Related Content
Recent News about Pain QX
EditPainQx is an innovative AI-powered medical device company that specializes in the objective measurement of chronic pain. The company operates in the healthcare technology market, focusing on providing advanced diagnostic tools for chronic pain assessment. PainQx's core product, the ALGOS System, utilizes sophisticated machine learning algorithms and EEG signal processing to accurately assess pain levels in patients. This system classifies pain into categories such as No Pain, Mild, Moderate, or Severe, which correlate with the patient's self-reported pain scores. The business primarily serves healthcare providers, including hospitals, clinics, and pain management specialists, who require precise and objective pain measurement tools to enhance patient care and treatment outcomes. PainQx generates revenue through the sale of its ALGOS System and related services, including software updates and maintenance. The company's business model is based on a combination of direct sales and partnerships with medical institutions. By leveraging proprietary algorithms and advanced EEG feature extraction techniques, PainQx aims to revolutionize the way chronic pain is diagnosed and managed, ultimately improving the quality of life for millions of patients worldwide.
Keywords: AI-powered, medical device, chronic pain, EEG signal processing, machine learning, pain assessment, healthcare technology, diagnostic tools, pain management, proprietary algorithms.